Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleNuclear Neurology

Iodine-123-Iodobenzamide SPECT Assessment of Dopamine D2 Receptor Occupancy in Risperidone-Treated Schizophrenic Patients

Stefan Dresel, Klaus Tatsch, Inga Dähne, Torsten Mager, Josef Scherer and Klaus Hahn
Journal of Nuclear Medicine July 1998, 39 (7) 1138-1142;
Stefan Dresel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klaus Tatsch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inga Dähne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Torsten Mager
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josef Scherer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klaus Hahn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 39, Issue 7
July 1, 1998
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Iodine-123-Iodobenzamide SPECT Assessment of Dopamine D2 Receptor Occupancy in Risperidone-Treated Schizophrenic Patients
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Iodine-123-Iodobenzamide SPECT Assessment of Dopamine D2 Receptor Occupancy in Risperidone-Treated Schizophrenic Patients
Stefan Dresel, Klaus Tatsch, Inga Dähne, Torsten Mager, Josef Scherer, Klaus Hahn
Journal of Nuclear Medicine Jul 1998, 39 (7) 1138-1142;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Iodine-123-Iodobenzamide SPECT Assessment of Dopamine D2 Receptor Occupancy in Risperidone-Treated Schizophrenic Patients
Stefan Dresel, Klaus Tatsch, Inga Dähne, Torsten Mager, Josef Scherer, Klaus Hahn
Journal of Nuclear Medicine Jul 1998, 39 (7) 1138-1142;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • D2 Receptor Occupancy During High- and Low-Dose Therapy with the Atypical Antipsychotic Amisulpride: A 123I-Iodobenzamide SPECT Study
  • Google Scholar

More in this TOC Section

  • Crossed Cerebellar Diaschisis Due TO Intracranial Hematoma in Basal Ganglia or Thalamus
  • PET Quantification of Specific Binding of Carbon-11-Nicotine in Human Brain
  • Regional Cerebral Blood Flow Scintigraphy in Tick-Borne Encephalitis and Other Aseptic Meningoencephalitis
Show more Nuclear Neurology

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire